Patients with chronic kidney disease are more willing to assume some risks of new medication as their disease advances, according to data published in Kidney Medicine.
Further, investigators found physicians might consider initiating risk vs. benefit conversations with patients when prescribing a new medication to slow disease progression. Read more.